GDF5 Polymorphism associated with osteoarthritis: risk for rheumatoid arthritis. (vol 67, pg 1352, 2008)

被引:0
|
作者
Martinez, A.
Varade, J.
Lamas, J. R.
机构
关键词
D O I
10.1136/ard.2007.085050.corr1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1080 / 1080
页数:1
相关论文
共 34 条
  • [21] Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II) (vol 67, pg 315, 2008)
    Krueger, K.
    Lino, L.
    Dore, R.
    Radominski, S.
    Zhang, Y.
    Kaur, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) : 732 - 732
  • [22] Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study (vol 59, pg 2898, 2020)
    Sarmanova, Aliya
    Doherty, Michael
    Kuo, Changfu
    Wei, Jie
    Abhishek, Abhishek
    Mallen, Christian
    Zeng, Chao
    Wang, Yilun
    Lei, Guanghua
    Zhang, Weiya
    RHEUMATOLOGY, 2020, 59 (10) : 3120 - 3120
  • [23] A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis
    Moriguchi, M
    Terai, C
    Kaneko, H
    Koseki, Y
    Kajiyama, H
    Uesato, M
    Inada, S
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 2001, 44 (06): : 1266 - 1272
  • [25] Identification of a single nucleotide polymorphism in the 5′ flanking region of SAA1 primarily associated with the risk of AA-amyloidosis in rheumatoid arthritis patients.
    Moriguchi, M
    Terai, C
    Kaneko, H
    Koseki, Y
    Kajiyama, H
    Uesato, M
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S270 - S270
  • [26] The PTPN22 R263Q Polymorphism Is a Risk Factor for Rheumatoid Arthritis in Caucasian Case-Control Samples (vol 63, pg 365, 2011)
    Rodriguez-Rodriguez, Luis
    Taib, Wan Rohani Wan
    Topless, Ruth
    Steer, Sophia
    Gonzalez-Escribano, Maria F.
    Balsa, Alejandro
    Pascual-Salcedo, Dora
    Gonzalez-Gay, Miguel A.
    Raya, Enrique
    Fernandez-Gutierrez, Benjamin
    Gonzalez-Alvaro, Isidoro
    Bottini, Nunzio
    Witte, Torsten
    Viken, Marte K.
    Coenen, Marieke J. H.
    van Riel, Piet L. C. M.
    Franke, Barbara
    den Heijer, Martin
    Radstake, Timothy R. D. J.
    Wordsworth, Paul
    Lie, Benedicte A.
    Merriman, Tony R.
    Martin, Javier
    ARTHRITIS AND RHEUMATISM, 2011, 63 (03): : 669 - 669
  • [27] Polymorphisms in genes encoding tumor necrosis factor-α and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis (vol 35, pg 177, 2008)
    Pinto, J. A.
    Rego, I.
    Rodriguez-Gomez, M.
    Canete, J. D.
    Fernandez-Lopez, C.
    Freire, A.
    Fernandez-Sueiro, J. L.
    Sanmarti, R.
    Blanco, F. J.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 546 - 546
  • [28] Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status (vol 49, pg 205, 2022)
    Yazdanyar, Ali
    Donato, Anthony
    Wasko, Mary Chester
    Ward, Michael M.
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (02) : 205 - 212
  • [29] Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. (vol 65, pg 699, 2005)
    Geborek, P.
    Bladstrom, A.
    Turesson, C.
    Gulfe, A.
    Petersson, I. F.
    Saxne, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3134 - 3134
  • [30] Site-specific absence of microfibrillar-associated protein 4 (MFAP4) from the internal elastic membrane of arterioles in the rheumatoid arthritis synovial membrane: an immunohistochemical study in patients with advanced rheumatoid arthritis versus osteoarthritis (vol 127, pg 588, 2019)
    Christensen, Anne Friesgaard
    Sorensen, Grill Lykke
    Junker, Kirsten
    Revald, Peter
    Varnum, Claus
    Issa, Saida Farah
    Sorensen, Flemming Brandt
    Junker, Peter
    APMIS, 2019, 127 (11) : 734 - 734